Concepedia

Murugesan Vanangamudi

MV

10

Publications

461

Citations

10

H-Index

2008

Active since

Affiliations

Central Drug Research Institute(Current)

National AIDS Research Institute

Swami Vivekanand College of Pharmacy

Mohanlal Sukhadia University

University of Bonn

Murugesan Vanangamudi is an author at Central Drug Research Institute specializing in medicine, drug discovery, and pharmacology.

ORCID

Top concepts

Publications per year

2008–2020

10

Publications

10

The Journey of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) from Lab to Clinic

Vigneshwaran Namasivayam, Murugesan Vanangamudi, Victor G. Kramer et al. · Journal of Medicinal Chemistry · 2018 · 177 citations · Full text

, , +16

Evaluation of 4-thiazolidinone derivatives as potential reverse transcriptase inhibitors against HIV-1 drug resistant strains

Rahul Suryawanshi, Sushama Jadhav, Nandini Makwana et al. · Bioorganic Chemistry · 2017 · 45 citations

, , +9

Lead optimization at C-2 and N-3 positions of thiazolidin-4-ones as HIV-1 non-nucleoside reverse transcriptase inhibitors

Murugesan Vanangamudi, Vinay Shankar Tiwari, Reshu Saxena et al. · Bioorganic & Medicinal Chemistry · 2011 · 40 citations

, , +12

CoMFA and CoMSIA studies on thiazolidin-4-one as anti-HIV-1 agents

Murugesan Vanangamudi, Yenamandra S. Prabhakar, S. B. Katti · Journal of Molecular Graphics and Modelling · 2008 · 38 citations

, , +9

Rational design and synthesis of novel thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitors

Murugesan Vanangamudi, Nandini Makwana, Rahul Suryawanshi et al. · Bioorganic & Medicinal Chemistry · 2014 · 38 citations

, , +8

Rows per page

1–5 of 10